Clinical Trials Directory

Trials / Completed

CompletedNCT01072916

Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)

The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The proposed pilot project for this seed grant focuses on the role of intestinal serine-proteases in the pathogenesis of diarrhea-predominant IBS (D-IBS). In this study we will further assess serine-protease activity in patients with D-IBS and also explore a possible mechanism by which these proteases can lead to alterations in intestinal physiology and symptoms in these patients. The general hypotheses for the proposed research are that (A) the levels of fecal serine-protease in patients with D-IBS are abnormally increased (B) this abnormal serine-protease activity leads to/is associated with an abnormal increase in intestinal permeability and therefore enables (C) chronic stimulation and activation of the mucosal immune system in these patients. In addition, it is aim to determine whither periodontal inflammation is associated with intestinal permeability and serine protease activity.

Conditions

Timeline

Start date
2009-02-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2010-02-22
Last updated
2016-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01072916. Inclusion in this directory is not an endorsement.